Incidence of omental metastasis in uterine serous carcinoma: a systematic review and meta-analysis

J Gynecol Obstet Hum Reprod. 2022 Jun;51(6):102395. doi: 10.1016/j.jogoh.2022.102395. Epub 2022 Apr 28.

Abstract

Objectives: Previous studies examining the incidence of omental metastasis in uterine serous carcinoma generally suffered from small sample size, retrospective observational design, and single-center setting. So far, there was no systematic review and meta-analysis available on this topic, we conducted this study to quantitatively synthesize the data relating to this topic.

Design: systematic review and meta-analysis.

Material and methods: PubMed, Embase, and Web of Science were searched up until August 15, 2020. Two reviewers independently performed study selection, data extraction, and quality assessment. I2 was employed to assess the heterogeneity among the included studies. Effect sizes along with 95% confidence intervals were calculated to analyze outcomes of interest. Funnel plots and the Egger test were used to detect the risk of publication bias.

Outcome measures: incidence of omental metastasis in uterine serous carcinoma.

Results: A total of 16 studies involving 1012 women with uterine serous carcinoma were included in this study. All the included studies were at low risk of bias, and the heterogeneity among them was low. The pooled incidence of overall omental metastasis, occult omental metastasis, and gross omental metastasis in uterine serous carcinoma were 18% (95% CI, 0.15-0.20), 6% (95% CI, 0.04-0.08), and 10% (95% CI, 0.08-0.13), respectively.

Conclusions: Uterine serous carcinoma has a high tendency of omental metastasis. The main form of omentum involvement is gross metastasis. However, occult metastasis in the normal-looking omentum is also worthy of note.

Keywords: Endometrial cancer; omental assessment; omental metastasis; uterine serous carcinoma.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Cystadenocarcinoma, Serous* / epidemiology
  • Female
  • Humans
  • Incidence
  • Peritoneal Neoplasms* / secondary
  • Retroperitoneal Neoplasms*
  • Retrospective Studies
  • Uterine Neoplasms* / epidemiology